Raju Mohan - 22 Dec 2022 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role
Chief Executive Officer, Director
Signature
/s/ Christopher W. Krueger, as Attorney-in-Fact
Issuer symbol
VTYX
Transactions as of
22 Dec 2022
Net transactions value
-$1,749,640
Form type
4
Filing time
23 Dec 2022, 17:35:08 UTC
Previous filing
20 Dec 2022
Next filing
18 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTYX Common Stock Sale $1,749,640 -55,354 -3.3% $31.61 1,603,126 22 Dec 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
F2 Represents the weighted average share price of an aggregate total of 55,354 shares sold in the price range of $31.60 to $31.887. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.